Hypertension, left ventricular hypertrophy and chronic kidney disease

Heart Failure Reviews

Volumn 16, Issue 6, 2011, Pages 615-620

  Taddei, Stefano ^a   Nami, Renato ^b   Bruno, Rosa Maria ^a   Quatrini, Ilaria ^b   Nuti, Ranuccio ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

CKD; Endothelial dysfunction; Hypertension; LVH; Mineral metabolism disorders

Indexed keywords

CALCITRIOL; ENDOTHELIN 1; ERYTHROPOIETIN; HEMOGLOBIN; N(G),N(G) DIMETHYLARGININE; PARATHYROID HORMONE; PHOSPHATE;

ANEMIA; ARTERIAL STIFFNESS; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DIASTOLIC BLOOD PRESSURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE MASS INDEX; HEART LEFT VENTRICLE OVERLOAD; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERPHOSPHATEMIA; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MINERAL METABOLISM; PULSE PRESSURE; PULSE WAVE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; SMOOTH MUSCLE FIBER; SODIUM RETENTION; SYSTOLIC BLOOD PRESSURE; WATER RETENTION;

ANEMIA; CARDIOVASCULAR AGENTS; CARDIOVASCULAR SYSTEM; CHRONIC DISEASE; EARLY DIAGNOSIS; EARLY MEDICAL INTERVENTION; HEMODYNAMICS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; METABOLISM; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VASCULAR RESISTANCE; WATER-ELECTROLYTE IMBALANCE;

EID: 79960325547     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-010-9197-z     Document Type: Article

References (55)

1. J Coresh GL Wei G McQuillan FL Brancati AS Levey C Jones, et al. 2001 Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 161 9 1207 1216 11343443 10.1001/archinte.161.9.1207 1:STN:280:DC%2BD3M3ptFSlsQ%3D%3D (Pubitemid 32691517)
2. R Agarwal AR Nissenson D Batlle DW Coyne JR Trout DG Warnock 2003 Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States Am J Med 115 4 291 297 12967694 10.1016/S0002-9343(03)00366-8 (Pubitemid 37088191)
3. AJ Collins RN Foley C Herzog B Chavers D Gilbertson A Ishani, et al. 2009 United States renal data system 2008 annual data report Am J Kidney Dis 53 Suppl 1 S1-374 19111206
4. R Hanratty M Chonchol LM Dickinson BL Beaty RO Estacio TD Mackenzie, et al. 2009 Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension (2010) Nephrol Dial Transplant 25 3 801 807 19889870 10.1093/ndt/gfp534
5. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J (2005) Global burden of hypertension: analysis of worldwide data. Lancet 15-21, 365(9455): 217-223 (Pubitemid 40138015)
6. M Ravera M Re L Deferrari S Vettoretti G Deferrari 2006 Importance of blood pressure control in chronic kidney disease J Am Soc Nephrol 17 42 S98 S103 16565257 10.1681/ASN.2005121319
7. DA Calhoun D Jones S Textor DC Goff TP Murphy RD Toto, et al. 2008 Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American heart association professional education committee of the council for high blood pressure research Circulation 117 25 e510 e526 18574054 10.1161/CIRCULATIONAHA.108.189141
8. VM Campese N Mitra D Sandee 2006 Hypertension in renal parenchymal disease: why is it so resistant to treatment? Kidney Int 69 6 967 973 16528245 10.1038/sj.ki.5000177 1:CAS:528:DC%2BD28XitFGhtL4%3D (Pubitemid 43372170)
9. ND Wong VA Lopez G L'Italien R Chen SE Kline SS Franklin 2007 Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004 Arch Intern Med 167 22 2431 2436 18071164 10.1001/archinte.167.22. 2431 (Pubitemid 350254901)
10. AS Go GM Chertow D Fan CE McCulloch CY Hsu 2004 Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 1296 1305 15385656 10.1056/NEJMoa041031 1:CAS:528:DC%2BD2cXnvFSgtr8%3D (Pubitemid 39268908)
11. GL Bakris E Ritz 2009 The message for World Kidney Day 2009: hypertension and kidney disease-a marriage that should be prevented J Hypertens 27 3 666 669 19262237 10.1097/HJH.0b013e328327706a 1:CAS:528:DC%2BD1MXisFOhu7o%3D
12. LM Ruilope A Salvetti K Jamerson L Hansson I Warnold H Wedel, et al. 2001 Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study J Am Soc Nephrol 12 2 218 225 11158211 1:STN:280:DC%2BD3M7mt1CjsQ%3D%3D (Pubitemid 32116363)
13. JF Mann HC Gerstein J Pogue J Bosch S Yusuf 2001 Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial Ann Intern Med 134 8 629 636 11304102 1:CAS:528: DC%2BD3MXjsV2ms7Y%3D (Pubitemid 32322240)
14. R Pontremoli A Sofia M Ravera C Nicolella F Viazzi A Tirotta, et al. 1997 Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: a Genoa investigation on complications Hypertension 5 1135 1143 (Pubitemid 27476170)
15. BF Culleton MG Larson PW Wilson JC Evans PS Parfrey D Levy 1999 Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency Kidney Int 56 6 2214 2219 10594797 10.1046/j.1523-1755.1999. 00773.x 1:STN:280:DC%2BD3c%2FmtlWjuw%3D%3D (Pubitemid 30004750)
16. J Arnlov JC Evans JB Meigs TJ Wang CS Fox D Levy, et al. 2005 Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study Circulation 112 7 969 975 16087792 10.1161/CIRCULATIONAHA.105.538132 (Pubitemid 41170264)
17. G Leoncini F Viazzi D Parodi S Vettoretti E Ratto M Ravera, et al. 2003 Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension Hypertension 42 1 14 18 12756221 10.1161/01.HYP.0000075789.58883.73 1:CAS:528:DC%2BD3sXkvVKmtr4%3D (Pubitemid 36842230)
18. P Vallance A Leone A Calver J Collier S Moncada 1992 Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure Lancet 339 8793 572 575 1347093 10.1016/0140-6736(92)90865-Z 1:STN:280: DyaK387mslOisw%3D%3D
19. RL Converse Jr TN Jacobsen RD Toto CM Jost F Cosentino F Fouad-Tarazi, et al. 1992 Sympathetic overactivity in patients with chronic renal failure N Engl J Med 327 27 1912 1918 1454086 10.1056/NEJM199212313272704 (Pubitemid 23006966)
20. F Mallamaci G Tripepi R Maas L Malatino R Boger C Zoccali 2004 Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease J Am Soc Nephrol 15 2 435 441 14747391 10.1097/01.ASN.0000106717.58091.F6 1:CAS:528:DC%2BD2cXhtV2itbw%3D (Pubitemid 38140785)
21. N Dhaun J Goddard DJ Webb 2006 The endothelin system and its antagonism in chronic kidney disease J Am Soc Nephrol 17 4 943 955 16540557 10.1681/ASN.2005121256 1:CAS:528:DC%2BD28XjvFSqsLc%3D
22. R Krapf HN Hulter 2009 Arterial hypertension induced by erythropoietin and erythropoiesis-stimulating agents (ESA) Clin J Am Soc Nephrol 4 2 470 480 19218474 10.2215/CJN.05040908 1:CAS:528:DC%2BD1MXjslagurY%3D
23. GM London SJ Marchais AP Guerin 2004 Arterial stiffness and function in end-stage renal disease Adv Chronic Kidney Dis 11 2 202 209 15216492 10.1053/j.arrt.2004.02.008 (Pubitemid 39295215)
24. A Yildiz E Memisoglu H Oflaz H Yazici H Pusuroglu V Akkaya, et al. 2005 Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients Nephrol Dial Transplant 20 4 760 767 15716296 10.1093/ndt/gfh611 (Pubitemid 40520654)
25. LS Ibels AC Alfrey WE Huffer PW Craswell JT Anderson R Weil 1979 Arterial calcification and pathology in uremic patients undergoing dialysis Am J Med 66 5 790 796 443254 10.1016/0002-9343(79)91118-5 1:STN:280:DyaE1M7osFSqsg%3D%3D (Pubitemid 9189336)
26. HC Stary AB Chandler RE Dinsmore V Fuster S Glagov W Insull Jr, et al. 1995 A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association Arterioscler Thromb Vasc Biol 15 9 1512 1531 7670967 10.1161/01.ATV.15.9.1512 1:STN:280:DyaK2MvgtVylsA%3D%3D
27. AP Guerin GM London SJ Marchais F Metivier 2000 Arterial stiffening and vascular calcifications in end-stage renal disease Nephrol Dial Transplant 15 7 1014 1021 10862640 10.1093/ndt/15.7.1014 1:STN:280:DC%2BD3cvjtVyhsA%3D%3D (Pubitemid 30410374)
28. WW Nichols DG Edwards 2001 Arterial elastance and wave reflection augmentation of systolic blood pressure: deleterious effects and implications for therapy J Cardiovasc Pharmacol Ther 6 1 5 21 11452332 10.1177/ 107424840100600102 1:STN:280:DC%2BD3MzpvVWisw%3D%3D (Pubitemid 32979883)
29. MJ Klag PK Whelton BL Randall JD Neaton FL Brancati CE Ford, et al. 1996 Blood pressure and end-stage renal disease in men N Engl J Med 334 1 13 18 7494564 10.1056/NEJM199601043340103 1:STN:280:DyaK287gsFakug%3D%3D (Pubitemid 26012498)
30. A Levin CR Thompson J Ethier EJ Carlisle S Tobe D Mendelssohn, et al. 1999 Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin Am J Kidney Dis 34 1 125 134 10401026 10.1016/S0272- 6386(99)70118-6 1:STN:280:DyaK1MzjtV2hsg%3D%3D (Pubitemid 29318806)
31. RN Foley PS Parfrey JD Harnett GM Kent CJ Martin DC Murray, et al. 1995 Clinical and echocardiographic disease in patients starting end-stage renal disease therapy Kidney Int 47 1 186 192 7731145 10.1038/ki.1995.22 1:STN:280:DyaK2M3kvVKmsw%3D%3D
32. RJ Middleton PS Parfrey RN Foley 2001 Left ventricular hypertrophy in the renal patient J Am Soc Nephrol 12 5 1079 1084 11316868 1:STN:280: DC%2BD3MvkvVenuw%3D%3D (Pubitemid 32378350)
33. Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, et al. (2005) Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 13, 293(14): 1737-1745
34. GM London 2003 Cardiovascular disease in chronic renal failure: pathophysiologic aspects Semin Dial 16 2 85 94 12641870 10.1046/j.1525-139X. 2003.16023.x (Pubitemid 37356820)
35. SY Hayashi M Rohani B Lindholm LA Brodin B Lind P Barany, et al. 2006 Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging Nephrol Dial Transplant 21 1 125 132 16221719 10.1093/ndt/gfi075 (Pubitemid 43057120)
36. JJ Hunter KR Chien 1999 Signaling pathways for cardiac hypertrophy and failure N Engl J Med 341 17 1276 1283 10528039 10.1056/NEJM199910213411706 1:CAS:528:DyaK1MXnt1Cqs70%3D (Pubitemid 29489744)
37. V Dilsizian JC Fink 2008 Deleterious effect of altered myocardial fatty acid metabolism in kidney disease J Am Coll Cardiol 51 2 146 148 18191739 10.1016/j.jacc.2007.09.032 1:CAS:528:DC%2BD1cXlsFCjsQ%3D%3D
38. DL Andress 2006 Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation Kidney Int 69 1 33 43 16374421 10.1038/sj.ki.5000045 1:CAS:528:DC%2BD28Xpt1WrtQ%3D%3D (Pubitemid 43117736)
39. Nami R, Ferro G, Gianni G, Mondillo S, Gonnelli S, Montagnani A et al (1997) Calciotropic hormones and cardiovascular function in chronic renal failure. In: Timio M, Wizemann V, Nenanzi S (eds) Cardionephrology, vol 4. Editoriale Bios, Cosenza, pp 83-85
40. SG Rostand TB Drueke 1999 Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure Kidney Int 56 2 383 392 10432376 10.1046/j.1523-1755.1999.00575.x 1:CAS:528:DyaK1MXltlOhuro%3D (Pubitemid 29353135)
41. M Smogorzewski M Zayed YB Zhang J Roe SG Massry 1993 Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytes Am J Physiol 264 6 Pt 2 H1998 H2006 8322930 1:CAS:528:DyaK3sXlslCmsb4%3D (Pubitemid 23205973)
42. GM London 2002 Left ventricular alterations and end-stage renal disease Nephrol Dial Transplant 17 Suppl 1 29 36 11812909 10.1093/ndt/17.suppl-1.29 (Pubitemid 34157116)
43. CW Park YS Oh YS Shin CM Kim YS Kim SY Kim, et al. 1999 Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism Am J Kidney Dis 33 1 73 81 9915270 10.1016/S0272-6386(99)70260-X 1:CAS:528:DyaK1MXmvVSjug%3D%3D
44. TD O'Connell JE Berry AK Jarvis MJ Somerman RU Simpson 1997 1, 25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy Am J Physiol 272 4 Pt 2 H1751 H1758 9139959
45. S Lemmila H Saha V Virtanen I Ala-Houhala A Pasternack 1998 Effect of intravenous calcitriol on cardiac systolic and diastolic function in patients on hemodialysis Am J Nephrol 18 5 404 410 9730564 10.1159/000013384 1:STN:280:DyaK1czpvFKqsA%3D%3D (Pubitemid 28442103)
46. HW Kim CW Park YS Shin YS Kim SJ Shin YS Kim, et al. 2006 Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis Nephron Clin Pract 102 1 c21 c29 16166802 10.1159/000088295 (Pubitemid 43250929)
47. YC Li J Kong M Wei ZF Chen SQ Liu LP Cao 2002 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system J Clin Invest 110 2 229 238 12122115 1:CAS:528:DC%2BD38XlsVGlsbg%3D (Pubitemid 34787360)
48. E Kristal-Boneh P Froom G Harari J Ribak 1997 Association of calcitriol and blood pressure in normotensive men Hypertension 30 5 1289 1294 9369290 1:CAS:528:DyaK2sXntlyht7c%3D (Pubitemid 27476193)
49. GM London AP Guerin FH Verbeke B Pannier P Boutouyrie SJ Marchais, et al. 2007 Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency J Am Soc Nephrol 18 2 613 620 17202417 10.1681/ASN.2006060573 1:CAS:528:DC%2BD2sXit12isrg%3D (Pubitemid 46193327)
50. S Jono A Shioi Y Ikari Y Nishizawa 2006 Vascular calcification in chronic kidney disease J Bone Miner Metab 24 2 176 181 16502129 10.1007/s00774-005- 0668-6
51. F Metivier SJ Marchais AP Guerin B Pannier GM London 2000 Pathophysiology of anaemia: focus on the heart and blood vessels Nephrol Dial Transplant 15 Suppl 3 14 18 11032352
52. DS Silverberg D Wexler B Blum A Iaina 2003 Anemia in chronic kidney disease and congestive heart failure Blood Purif 21 1 124 130 12596758 10.1159/000067856 1:STN:280:DC%2BD3s%2FosFSgtA%3D%3D (Pubitemid 36173359)
53. A Levin O Djurdjev C Thompson B Barrett J Ethier E Carlisle, et al. 2005 Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD Am J Kidney Dis 46 5 799 811 16253719 10.1053/j.ajkd.2005.08.007 1:CAS:528:DC%2BD2MXht1Olu77O (Pubitemid 41505453)
54. DE Weiner H Tighiouart PT Vlagopoulos JL Griffith DN Salem AS Levey, et al. 2005 Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease J Am Soc Nephrol 16 6 1803 1810 15857925 10.1681/ASN.2004070597 (Pubitemid 41716487)
55. E Paoletti G Cannella 2006 Left ventricular hypertrophy in chronic kidney disease G Ital Nefrol 23 6 560 568 17173262 1:STN:280:DC%2BD2s%2FnsFWisQ%3D%3D